Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01318577 · ClinicalTrials.gov registry record · NA
Study of A New Contact Lens Cleaning and Disinfecting Solution
A NA study, sponsored by Bausch & Lomb Incorporated.
- Completed
- Registry status
- NA
- Development phase
- 444
- Enrollment target
NCT01318577: Completed NA study, sponsored by Bausch & Lomb Incorporated.
NCT01318577 is a NA study that has completed, run by Bausch & Lomb Incorporated. The registered enrollment target is 444 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (68% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01318577, a NA study, has completed, sponsored by Bausch & Lomb Incorporated.
- COMPLETED
- Registry status
- NA
- Development phase
- 444 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate the safety and efficacy of a new investigational cleaning and disinfecting solution (Test) compared to Clear Care cleaning and disinfecting solution (Control) when used by contact lens wearers to clean and disinfect their contact lenses for approximately three months.
Primary Outcome
Graded slit lamp findings for each eye, including epithelial edema, epithelial microcysts, corneal staining, limbal and bulbar injections, upper lid tarsal conjunctival abnormalities, corneal neovascularization, and corneal infiltrates were graded for severity on a scale from 0 (No Finding) to 4 (Severe Finding). The outcome measure is any finding \> grade 2, across abnormalities.
Interventions
- DEVICE Investigational Cleaning & Disinfecting Solution
- DEVICE Clear Care Solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 444 participants |
| Start Date | 2010-11 |
| Est. Completion | 2011-06 |
| Phase | NA |
What the finished NCT01318577 record still lists
NCT01318577 is an interventional study that assigns participants to a tested intervention. The registered 444 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (68% lower).
The record links to 0 conditions, and to 2 interventions - of which Investigational Cleaning & Disinfecting Solution is the first listed.
NCT01318577 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01318577 about?
NCT01318577 is a clinical study titled "Study of A New Contact Lens Cleaning and Disinfecting Solution". The objective of this study is to evaluate the safety and efficacy of a new investigational cleaning and disinfecting solution (Test) compared to Clear Care cleaning and disinfecting solution (Control) when used by contact lens wearers to clean and disinfect their contact lenses for approximately th...
What is the current status of trial NCT01318577?
This trial is currently completed. It is a NA study. The enrollment target is 444 participants. The study started on 2010-11. Estimated completion is 2011-06.
What interventions are being tested in trial NCT01318577?
The interventions under investigation include: Investigational Cleaning & Disinfecting Solution (DEVICE), Clear Care Solution (DEVICE).
Who is sponsoring clinical trial NCT01318577?
This trial is sponsored by Bausch & Lomb Incorporated, which has 174 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01318577's enrollment target sits among peer trials
444 233rd of 2000 higher than 1,768 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06348394 · 444 participants · NA
Intracardiac Versus Transesophageal Echocardiographic Guidance for Left Atrial Appendage Occlusion
- NCT06700343 · 444 participants · Phase 3
Comparison Between ABP 692 and Ocrevus® (Ocrelizumab)
- NCT01280994 · 445 participants · Phase 2
Hyperpolarized 129Xe MRI for Imaging Pulmonary Function
- NCT03504800 · 445 participants
OCT in Diagnosis of Irregular Corneas
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia